Today: 8 June 2026
Browse Category

NASDAQ:CMPS 4 November 2025 - 18 May 2026

Compass Pathways Rallies Pre-Market on FDA Trade Speculation

Compass Pathways Rallies Pre-Market on FDA Trade Speculation

Compass Pathways shares jumped 19.5% to $12.39 in U.S. premarket trading Monday after the company announced a faster FDA review path for its COMP360 psilocybin treatment. Management will address investors Tuesday at the RBC Capital Markets conference. Compass ended March with $466 million in cash and reported a first-quarter operating loss of $42.9 million.
18 May 2026
·
COMPASS Pathways (CMPS) Psychedelic Breakthrough Stock – Latest News, Analysis & 2025 Outlook

COMPASS Pathways (CMPS) Psychedelic Breakthrough Stock – Latest News, Analysis & 2025 Outlook

COMPASS Pathways’ stock traded near $6 on Nov. 4, 2025, flat after a recent pullback and well above mid-year lows. The company reported a net loss of $137.7 million in Q3, with $185.9 million in cash on hand. Its lead psilocybin therapy met the primary endpoint in a Phase 3 trial for treatment-resistant depression in June. COMPASS is accelerating commercial plans and expects key data readouts in 2026.
4 November 2025
·

Stock Market Today

  • Ambev Market Outlook: Investor Sentiment Cools
    June 8, 2026, 3:15 AM EDT. The market sentiment for Ambev (ABEV) has recently cooled, reflecting a sober investor stance amid broader economic uncertainties. An experienced analyst with nearly two decades in logistics and a decade in stock investing highlights his diversified holdings across ASEAN and US markets, including Ambev shares. He emphasizes long-term investment balanced with trading strategies, noting no compensation or business ties influencing his perspective. This cautious outlook underscores the need for investors to evaluate fundamentals carefully, amid changing market dynamics and varied sector performances.

Latest articles

Snap Drops 5%—Ad Recovery Eyed Next

Snap Drops 5%—Ad Recovery Eyed Next

8 June 2026
Snap closed Friday at $5.76, down 5.11% amid a broad tech selloff triggered by a strong jobs report and renewed rate-hike worries, but still ended the week up 0.9%. Investors now await U.S. inflation data and CEO Evan Spiegel’s June 16 AWE keynote on Specs, as Snap faces pressure from weak North American ad revenue, tough competition, and activist demands for cost cuts.
Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

Navitas’ Nvidia-Led Rally Stalls, Eyes on AI Trade Next Week

8 June 2026
Navitas plunged $5.61 to $25.08 Friday as a $1.3 trillion chip selloff erased Nvidia-driven gains, despite news it issued 3.28 million shares for merger earn-outs and showcased its GaNFast power board at Nvidia’s AI MGX event; investors now face risks from share dilution, sector volatility, and Navitas’s early-stage pivot to high-power AI markets amid ongoing operating losses.
NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

NIO Stock Drops Even as Deliveries Jump, Focus Turns to June Numbers

8 June 2026
NIO’s U.S.-listed shares plunged 5.8% Friday, erasing a delivery-led rally, as investors focus on whether June sales can hit the company’s Q2 target after May deliveries rose 62.3% to 37,705. NIO needs 42,939–47,939 June deliveries to meet guidance, with risks from China’s saturated car market and recent price pressure.
HPE Stock Faces AI Rally Test With Monday In Focus

HPE Stock Faces AI Rally Test With Monday In Focus

8 June 2026
Hewlett Packard Enterprise plunged 8.36% Friday to $49.20, capping a three-day slide and erasing gains after a post-earnings surge, even as it raised its fiscal 2026 revenue growth outlook to 29%-33% and boosted non-GAAP EPS guidance, with analysts warning that rapid gains may have priced in too much hope too quickly.
Go toTop